产品中心 抗体 其他一抗

所有图片(1/5)

elF4A1 Rabbit Polyclonal Antibody

Eukaryotic initiation factor 4A-I,eIF-4A-I,eIF4A-I,ATP-dependent RNA helicase eIF4A-1,DDX2A,EIF4A

价格 400.00 供应商现货 : 3-5个工作日
货号 S0B1046
规格
数量
收藏 分享

产品介绍 FAQs 评论(0)

产品规格
  • 宿主来源

    Rabbit
  • 抗原名称

    elF4A1
  • 分子别名

    Eukaryotic initiation factor 4A-I; eIF-4A-I; eIF4A-I; ATP-dependent RNA helicase eIF4A-1; DDX2A; EIF4A
  • 免疫原

    Synthetic Peptide
  • 细胞定位

    Cytoplasm, Nucleus
  • Accession

    P60842
  • 抗体类型

    Polyclonal antibody
  • 抗体同种型

    IgG
  • 反应种属 ?

    Hu, Ms, Rt
  • 阳性样本

    HEK-293, HeLa, Jurkat, A431, NIH/3T3, mouse liver, PC-12, C6
  • 预测反应种属
    (反应种属缩写表)

    CyMk, Or, Rb
  • 纯化方式

    Immunogen Affinity
  • 浓度

    0.5 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300

  • 储存条件

    12 months from date of receipt / reconstitution, -20 °C as supplied

  • 应用

    ICC ?

    WB

    IP

  • 稀释度

    应用 稀释度 推荐种属
    WB 1:1000 Hu, Ms, Rt
    IP 1:50 Hu
    ICC 1:500 Hu
背景介绍
  • eIF4A1, or eukaryotic translation initiation factor 4A1, is a protein that plays a crucial role in the initiation of translation in eukaryotic cells. It is one of the subunits of the eIF4F complex, which is responsible for unwinding the secondary structure of the mRNA 5' untranslated region (5' UTR) to facilitate the binding of the 40S ribosomal subunit to the start codon. Deregulated translation initiation, including the overactivity of eIF4A1, is implicated in cancer initiation and progression. This makes eIF4A1 an attractive target for cancer therapeutics. Researchers are actively pursuing strategies that target eIF4A1 to inhibit tumor growth and proliferation. Several natural product molecules, such as Rocaglamide A (RocA), have been reported to target eIF4A1, but their clinical utilization has been limited due to pharmacological limitations. In the context of cancer, eIF4A1 has been associated with poor outcomes in diffuse large B cell lymphoma (DLBCL). Higher expression levels of eIF4A1 are linked to shorter overall survival and progression-free survival in patients with DLBCL. This suggests that eIF4A1 expression could serve as a prognostic biomarker for this type of cancer. eIF4A1 is also involved in the translation of specific mRNAs that have complex secondary structures or are under translational control by factors such as the mTOR pathway. During mTORC1 inhibition, eIF4A1 enhances the translational repression mediated by LARP1 (La-related protein 1), which is a key regulator of mRNA translation.

  • 免疫印迹

    • WB result of elF4A1 Rabbit pAb
      Primary antibody: elF4A1 Rabbit pAb at 1/1000 dilution
      Lane 1: HEK-293 whole cell lysate 20 µg
      Lane 2: HeLa whole cell lysate 20 µg
      Lane 3: Jurkat whole cell lysate 20 µg
      Lane 4: A431 whole cell lysate 20 µg
      Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 46 kDa
      Observed MW: 46 kDa

    • WB result of elF4A1 Rabbit pAb
      Primary antibody: elF4A1 Rabbit pAb at 1/1000 dilution
      Lane 1: NIH/3T3 whole cell lysate 20 µg
      Lane 2: mouse liver lysate 20 µg
      Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 46 kDa
      Observed MW: 46 kDa

    • WB result of elF4A1 Rabbit pAb
      Primary antibody: elF4A1 Rabbit pAb at 1/1000 dilution
      Lane 1: PC-12 whole cell lysate 20 µg
      Lane 2: C6 whole cell lysate 20 µg
      Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 46 kDa
      Observed MW: 46 kDa

  • 免疫沉淀

    • elF4A1 Rabbit pAb at 1/50 dilution (1 µg) immunoprecipitating elF4A1 in 0.4 mg HeLa whole cell lysate.
      Western blot was performed on the immunoprecipitate using elF4A1 Rabbit pAb at 1/1000 dilution.
      Secondary antibody (HRP) for IP was used at 1/1000 dilution.
      Lane 1: HeLa whole cell lysate 20 µg (Input)
      Lane 2: elF4A1 Rabbit pAb IP in HeLa whole cell lysate
      Lane 3: Rabbit monoclonal IgG IP in HeLa whole cell lysate
      Predicted MW: 46 kDa
      Observed MW: 46 kDa

  • 免疫细胞化学

    • ICC shows positive staining in HeLa cells. Anti- elF4A1 antibody was used at 1/500 dilution (Green) and incubated overnight at 4°C. Goat polyclonal Antibody to Rabbit IgG - H&L (Alexa Fluor® 488) was used as secondary antibody at 1/1000 dilution. The cells were fixed with 4% PFA and permeabilized with 0.1% PBS-Triton X-100. Nuclei were counterstained with DAPI (Blue). Counterstain with tubulin (Red).

FAQs

斯达特公司的抗体,可以回收利用几次?

我们一般不推荐客户回收利用抗体。 因为抗体使用之后缓冲体系已经发生改变,不同客户在回收抗体的保存条件上也会有差异,所以抗体回收使用效果无法保证。另外,我们对一批抗体回收验证测试,测试结果显示不同抗体可回收次数不同,一般效价越高的抗体,可重复使用的次数越多,客户可根据实验情况来确定

评论(0)